Blog articles

'Transformational' cardiomyopathy treatment receives funding
We explore a recently funded heart muscle disease project that will use RNA therapy and gene editing in tandem

Cancer vs the immune system
This week, we explore the ways cancer cells can evade our bodies’ defences and how we can fight back

Trial underway for hATTR therapy
The novel ‘one off’ treatment could change the lives of those living with the condition

Key genomic technologies of 2020: treatments old and new
In the second part of our review of the year’s genomic highlights, we look at the breakthroughs that are helping patients with rare disease and cancer

RNA-based therapies: two types explained
What are RNA therapies and how are they used? We compare the two licensed types – antisense and RNA interference – to find out more

Mitochondrial disease: the genomics challenge
Mitochondrial diseases are overwhelmingly genetic in origin, so why are gene therapies so difficult to develop? We take a deep dive to find out more.

Genome editing trial suggests cure for blood diseases
Recent tests have established a potential cure for sickle cell disease and beta thalassaemia by using genome editing on bone marrow stem cells

Prime editing: the new kid on the block
Progress in the field of gene editing has been rapid, but one relatively new technique could be useful for up to 90% of known disease-causing variants

Genomics and HIV: can we be cured?
New genomic discoveries provide hope that lifelong antiretroviral therapy may one day be a thing of the past

Infectious diseases and the race to diagnosis
Researchers are exploring new techniques to tackle serious infectious diseases, and contain an outbreak before it becomes an epidemic

HIV and the genome
Genome editing has not been without controversies, but some studies suggest it may hold the cure for patients living with HIV
Events

LinkAGE Webinar 2: CRISPR
Welcome to the second of our new series of expert webinars. In this second webinar Dr James Patterson will discuss CRISPR.